You are subscribed to the Drug Topics Hospital Pharmacists' Report. Unsubscribe here..

Drug Topics Hospital Pharmacists' Report

Print Subscribe

Digital Edition Subscribe

January 4, 2013

Web Version  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

TOP STORY

Medical therapy for PVI reduces repeat procedures

The use of aspirin, statins, and lifestyle changes prior to elective peripheral vascular intervention (PVI) for peripheral arterial disease (PAD) may reduce the risk for repeat procedures within six months, according to researchers. However, about half of patients failed to receive this therapy, the researchers found. » More

Continuing Education

New CPE Series: December activity available now

Welcome to the fourth activity of our CPE series: Medication Therapy Management (MTM) in Patients with Diabetes, which has been designed for pharmacists who take care of patients with diabetes. You can earn up to 14 credits from September 2012-March 2013 with 7 monthly knowledge-based activities. The December activity will cover insulin therapy for diabetes care management.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

TODAY'S HEADLINES

FDA alerts doctors to counterfeit drugs

The FDA has warned more than 350 medical practices that they may have received counterfeit, contaminated, or ineffective medications. » More

Vitamin D deficiency linked to autism

Vitamin D deficiency may increase risk for developing autism, a researcher suggests. » More

Apixaban can treat nonvalvular atrial fibrillation

FDA announced recently it approved apixaban (Eliquis, Bristol-Myers Squibb and Pfizer) to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. » More

TAKE OUR SURVEY

Are you counseling more oncology patients to help with their medication regimens?

- Yes
- No

Click Here to let us know.

 

Subscribe Now!

You must click here to continue receiving the Drug Topics Hospital Pharmacists' Report

Check these out too

Touro pharmacy students at ASHP Midyear

Quit-smoking aid may lead to heart risks

2016 global drug spending at $1 trillion

Multidrug-resistant organisms surveillance

Voices

Anticoagulation Update

JP at Large: Loaded doesn't kill you

View from the Zoo: Goal of improved health may fall short despite increased pharmacy workload

Viewpoints: Guest columnists' commentary

Regulatory and Legal: News and analysis

Meetings and Events

 
Powered by Modern Medicine Advanstar Medical Communications Group